retatrutide clinical trial duration The drug is manufactured by Eli Lilly and is not FDA approved, however, one person gained access to the prescription through a program that approves experimental treatments for patients traditionally suffering π Retatrutide may be redefining
Description
The main difference is that Mounjaro is approved for type 2 diabetes while Zepbound is approved specifically for weight management
A small trial including 8 patients with T1D showed improved postprandial hyperglycemia despite 20% insulin dose reduction (69)
It is a "triple agent" that targets GIP, GLP-1, and glucagon receptors at the same time beyond the existing GLP-1 family
M., & Rico, E
These need to be part of informed consent regardless of dose
That substitution blocks DPP-4 from cleaving it
